Efficacy of secukinumab in patients with moderate-to-severe hidradenitis suppurativa previously treated with biologic therapy: Week 16 results from the SUNSHINE and SUNRISE trials

Efficacy of secukinumab in patients with moderate-to-severe hidradenitis suppurativa previously treated with biologic therapy: Week 16 results from the SUNSHINE and SUNRISE trials Meeting Abstract

publication date

September 1, 2023

webpage

Web of Science

published in

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY Journal

start page

AB160

end page

AB160

volume

89

issue

3